Thor Medical ASA (OSL: TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
1.018
-0.006 (-0.59%)
Aug 30, 2024, 4:25 PM CET
-21.69%
Market Cap 239.09M
Revenue (ttm) n/a
Net Income (ttm) -26.56M
Shares Out 234.86M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 360,398
Open 1.050
Previous Close 1.024
Day's Range 1.000 - 1.050
52-Week Range 0.850 - 1.940
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Aug 27, 2024

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was founded in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.